Invention Grant
- Patent Title: Ice-based lipid nanoparticle formulation for delivery of mRNA
-
Application No.: US16599928Application Date: 2019-10-11
-
Publication No.: US11013812B2Publication Date: 2021-05-25
- Inventor: Frank DeRosa , Michael Heartlein , Shrirang Karve
- Applicant: Translate Bio, Inc.
- Applicant Address: US MA Lexington
- Assignee: Translate Bio, Inc.
- Current Assignee: Translate Bio, Inc.
- Current Assignee Address: US MA Lexington
- Agency: Proskauer Rose LLP
- Agent Fangli Chen
- Main IPC: A61K47/54
- IPC: A61K47/54 ; A61K9/00 ; A61K48/00 ; A61K47/69 ; A61K47/60 ; A61K38/17 ; A61P11/12 ; A61K9/127 ; A61K47/28

Abstract:
The present invention provides, among other things, compositions and methods of formulating nucleic acid-containing nanoparticles comprising no more than three distinct lipids components, one distinct lipid component being a sterol-based cationic lipid. In some embodiments, the present invention provides compositions and methods in which the lipid nanoparticles further comprise helper lipids and PEG-modified lipids. The resulting formulation comprises a high encapsulation percentage for nucleic acids.
Public/Granted literature
- US20200038515A1 ICE-BASED LIPID NANOPARTICLE FORMULATION FOR DELIVERY OF MRNA Public/Granted day:2020-02-06
Information query